Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer

NCT04671511 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
98
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Jewish General Hospital

Collaborators